{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:58:08Z","timestamp":1779148688691,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12035-017-0455-0","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T05:06:30Z","timestamp":1489381590000},"page":"2162-2173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cyclooxygenase-2 Directs Microglial Activation-Mediated Inflammation and Oxidative Stress Leading to Intrinsic Apoptosis in Zn-Induced Parkinsonism"],"prefix":"10.1007","volume":"55","author":[{"given":"Amit Kumar","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namrata","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra Kumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetna","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"455_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144","journal-title":"Free Radic Biol Med"},{"key":"455_CR2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-011-8225-x","volume":"45","author":"NK Singhal","year":"2012","unstructured":"Singhal NK, Srivastava G, Agrawal S, Jain SK, Singh MP (2012) Melatonin as a neuroprotective agent in the rodent models of Parkinson\u2019s disease: is it all set to irrefutable clinical translation? Mol Neurobiol 45:186\u2013199","journal-title":"Mol Neurobiol"},{"key":"455_CR3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.freeradbiomed.2012.02.005","volume":"52","author":"G Srivastava","year":"2012","unstructured":"Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP (2012) Resveratrol potentiates cytochrome P450 2d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radic Biol Med 52:1294\u20131306","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"455_CR4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909","journal-title":"Neuron"},{"issue":"2","key":"455_CR5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/enrs.2001.4264","volume":"86","author":"A Priyadarshi","year":"2001","unstructured":"Priyadarshi A, Khuder SA, Schaub EA, Priyadarshi SS (2001) Environmental risk factors and Parkinson\u2019s disease: a metaanalysis. Environ Res 86(2):122\u2013127","journal-title":"Environ Res"},{"issue":"5","key":"455_CR6","first-page":"19","volume":"53","author":"C Singh","year":"2007","unstructured":"Singh C, Ahmad I, Kumar A (2007) Pesticides and metals induced Parkinson\u2019s disease: involvement of free radicals and oxidative stress. Cell Mol Biol (Noisy-le-grand) 53(5):19\u201328","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"1\u20132","key":"455_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","volume":"345","author":"K Jomova","year":"2010","unstructured":"Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345(1\u20132):91\u2013104","journal-title":"Mol Cell Biochem"},{"issue":"Pt 4","key":"455_CR8","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(Pt 4):1953\u20131975","journal-title":"Brain"},{"issue":"8","key":"455_CR9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3109\/10715762.2010.492832","volume":"44","author":"A Kumar","year":"2010","unstructured":"Kumar A, Ahmad I, Shukla S, Singh BK, Patel DK, Pandey HP, Singh C (2010) Effect of zinc and paraquat co-exposure on neurodegeneration: modulation of oxidative stress and expression of metallothioneins, toxicant responsive and transporter genes in rats. Free Radic Res 44(8):950\u2013965","journal-title":"Free Radic Res"},{"issue":"10","key":"455_CR10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3109\/10715762.2011.607164","volume":"45","author":"BK Singh","year":"2011","unstructured":"Singh BK, Kumar A, Ahmad I, Kumar V, Patel DK, Jain SK, Singh C (2011) Oxidative stress in zinc-induced dopaminergic neurodegeneration: implications of superoxide dismutase and heme oxygenase-1. Free Radic Res 45(10):1207\u20131222","journal-title":"Free Radic Res"},{"key":"455_CR11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2011.12.028","volume":"1438","author":"A Kumar","year":"2012","unstructured":"Kumar A, Singh BK, Ahmad I, Shukla S, Patel DK, Srivastava G, Kumar V, Pandey HP et al (2012) Involvement of NADPH oxidase and glutathione in zinc-induced dopaminergic neurodegeneration in rats: similarity with paraquat neurotoxicity. Brain Res 1438:48\u201364","journal-title":"Brain Res"},{"issue":"5","key":"455_CR12","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s12035-015-9137-y","volume":"53","author":"V Kumar","year":"2016","unstructured":"Kumar V, Singh BK, Chauhan AK, Singh D, Patel DK, Singh C (2016) Minocycline rescues from zinc-induced nigrostriatal dopaminergic neurodegeneration: biochemical and molecular interventions. Mol Neurobiol 53(5):2761\u20132777","journal-title":"Mol Neurobiol"},{"issue":"8","key":"455_CR13","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1007\/s12035-015-9478-6","volume":"53","author":"AK Chauhan","year":"2016","unstructured":"Chauhan AK, Mittra N, Kumar V, Patel DK, Singh C (2016) Inflammation and B-cell lymphoma-2 associated X protein regulate zinc-induced apoptotic degeneration of rat nigrostriatal dopaminergic neurons. Mol Neurobiol 53(8):5782\u20135795","journal-title":"Mol Neurobiol"},{"key":"455_CR14","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1007\/s12035-015-9577-4","volume":"53","author":"A Singh","year":"2016","unstructured":"Singh A, Tripathi P, Prakash OP, Singh MP (2016) Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration. Mol Neurobiol 53:6849\u20136858","journal-title":"Mol Neurobiol"},{"issue":"13","key":"455_CR15","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/mds.21552","volume":"22","author":"AL Bartels","year":"2007","unstructured":"Bartels AL, Leenders KL (2007) Neuroinflammation in the pathophysiology of Parkinson\u2019s disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord 22(13):1852\u20131856","journal-title":"Mov Disord"},{"issue":"3","key":"455_CR16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.molmed.2012.12.003","volume":"19","author":"YM Nolan","year":"2013","unstructured":"Nolan YM, Sullivan AM, Toulouse A (2013) Parkinson\u2019s disease in the nuclear age of neuroinflammation. Trends Mol Med 19(3):187\u2013196","journal-title":"Trends Mol Med"},{"issue":"8","key":"455_CR17","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60(8):1059\u20131064","journal-title":"Arch Neurol"},{"issue":"19","key":"455_CR18","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/01.wnl.0000279519.99344.ad","volume":"69","author":"AD Wahner","year":"2007","unstructured":"Wahner AD, Bronstein JM, Bordelon YM, Ritz B (2007) Nonsteroidal anti-inflammatory drugs may protect against Parkinson\u2019s disease. Neurology 69(19):1836\u20131842","journal-title":"Neurology"},{"issue":"8","key":"455_CR19","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291","journal-title":"Neurology"},{"issue":"1","key":"455_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","volume":"318","author":"P Teismann","year":"2004","unstructured":"Teismann P, Schulz JB (2004) Cellular pathology of Parkinson\u2019s disease: astrocytes, microglia and inflammation. Cell Tissue Res 318(1):149\u2013161","journal-title":"Cell Tissue Res"},{"issue":"2","key":"455_CR21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994a) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180(2):147\u2013150","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"455_CR22","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T (1994b) Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165(1\u20132):208\u2013210","journal-title":"Neurosci Lett"},{"issue":"8","key":"455_CR23","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role for cytokines. Curr Pharm Des 11(8):999\u20131016","journal-title":"Curr Pharm Des"},{"key":"455_CR24","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","volume":"94","author":"S Hunot","year":"1997","unstructured":"Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y et al (1997) Nuclear translocation of NFkappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A 94:7531\u20137536","journal-title":"Proc Natl Acad Sci U S A"},{"key":"455_CR25","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","volume":"991","author":"P Teismann","year":"2003","unstructured":"Teismann P, Vila M, Choi DK, Tieu K, Wu DC, Jackson-Lewis V, Przedborski S (2003) COX-2 and neurodegeneration in Parkinson\u2019s disease. Ann N Y Acad Sci 991:272\u2013277","journal-title":"Ann N Y Acad Sci"},{"key":"455_CR26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s11064-010-0176-5","volume":"35","author":"SP Gupta","year":"2010","unstructured":"Gupta SP, Patel S, Yadav S, Singh AK, Singh S, Singh MP (2010) Involvement of nitric oxide in maneb- and paraquat-induced Parkinson\u2019s disease. Neurochem Res 35:1206\u20131213","journal-title":"Neurochem Res"},{"issue":"1","key":"455_CR27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/157015910790909485","volume":"8","author":"AL Bartels","year":"2010","unstructured":"Bartels AL, Leenders KL (2010) Cyclooxygenase and neuroinflammation in Parkinson\u2019s disease neurodegeneration. Curr Neuropharmacol 8(1):62\u201368","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"455_CR28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","volume":"63","author":"L Minghetti","year":"2004","unstructured":"Minghetti L (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol 63(9):901\u2013910","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"455_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jnr.20541","volume":"81","author":"E Carrasco","year":"2005","unstructured":"Carrasco E, Casper D, Werner P (2005) Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity. J Neurosci Res 81(1):121\u2013131","journal-title":"J Neurosci Res"},{"issue":"2","key":"455_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","volume":"36","author":"G Dannhardt","year":"2001","unstructured":"Dannhardt G, Kiefer W (2001) Cyclooxygenase inhibitors\u2014current status and future prospects. Eur J Med Chem 36(2):109\u2013126","journal-title":"Eur J Med Chem"},{"issue":"2","key":"455_CR31","doi-asserted-by":"crossref","first-page":"81s","DOI":"10.18433\/J3T886","volume":"11","author":"P Rao","year":"2008","unstructured":"Rao P, Knaus EE (2008) Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 11(2):81s\u2013110s","journal-title":"J Pharm Pharm Sci"},{"issue":"3","key":"455_CR32","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","volume":"329","author":"ZH Feng","year":"2002","unstructured":"Feng ZH, Wang TG, Li DD, Fung P, Wilson BC, Liu B, Ali SF, Langenbach R et al (2002) Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett 329(3):354\u2013358","journal-title":"Neurosci Lett"},{"key":"455_CR33","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/01.WCB.0000130866.25040.7D","volume":"24","author":"K Chu","year":"2004","unstructured":"Chu K, Jeong SW, Jung KH, Han SY, Lee ST, Kim M, Roh JK (2004) Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death. J Cereb Blood Flow Metab 24:926\u2013933","journal-title":"J Cereb Blood Flow Metab"},{"key":"455_CR34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Bio Chem 193:265\u2013275","journal-title":"J Bio Chem"},{"issue":"3","key":"455_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","volume":"89","author":"CM Long-Smith","year":"2009","unstructured":"Long-Smith CM, Sullivan AM, Nolan YM (2009) The influence of microglia on the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 89(3):277\u2013287","journal-title":"Prog Neurobiol"},{"issue":"5","key":"455_CR36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","volume":"6","author":"RL Mosley","year":"2007","unstructured":"Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE (2007) Neuroinflammation, oxidative stress and the pathogenesis of Parkinson\u2019s disease. Clin Neurosci Res 6(5):261\u2013281","journal-title":"Clin Neurosci Res"},{"issue":"1","key":"455_CR37","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-1-6","volume":"1","author":"R Sanchez-Pernaute","year":"2004","unstructured":"Sanchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O (2004) Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson\u2019s disease. J Neuroinflammation 1(1):6","journal-title":"J Neuroinflammation"},{"issue":"4","key":"455_CR38","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2007.09.059","volume":"150","author":"X Zhang","year":"2007","unstructured":"Zhang X, Dong F, Mayer GE, Bruch DC, Ren J, Culver B (2007) Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats. Neuroscience 150(4):950\u2013958","journal-title":"Neuroscience"},{"key":"455_CR39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","volume":"3","author":"R Vijitruth","year":"2006","unstructured":"Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson\u2019s disease. J Neuroinflammation 3:6","journal-title":"J Neuroinflammation"},{"issue":"2","key":"455_CR40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","volume":"39","author":"P Teismann","year":"2001","unstructured":"Teismann P, Ferger B (2001) Inhibition of cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson\u2019s disease. Synapse 39(2):167\u2013174","journal-title":"Synapse"},{"key":"455_CR41","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/00001756-200310270-00009","volume":"14","author":"Z Feng","year":"2003","unstructured":"Feng Z, Li D, Fung PC, Pei Z, Ramsden DB, Ho SL (2003) COX-2 deficient mice are less prone to MPTP-neurotoxicity than wild-type kice. Neuroreport 14:1927\u20131929","journal-title":"Neuroreport"},{"issue":"6","key":"455_CR42","first-page":"577","volume":"48","author":"A Gupta","year":"2010","unstructured":"Gupta A, Dhir A, Kumar A, Kulkarni SK (2010) Effect of preferential cyclooxygenase-2 (COX-2) inhibitor against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced striatal lesions in rats: behavioral, biochemical and histological evidences. Indian J Exp Biol 48(6):577\u2013585","journal-title":"Indian J Exp Biol"},{"key":"455_CR43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/biof.1035","volume":"38","author":"P Teismann","year":"2012","unstructured":"Teismann P (2012) Cox-2 in the neurodegenerative process of Parkinson\u2019s disease. Biofactors 38:395\u2013397","journal-title":"Biofactors"},{"key":"455_CR44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti E, Fitzgerald GA (2011) Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 31:986\u20131000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"455_CR45","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2457fje","volume":"19","author":"T Wang","year":"2005","unstructured":"Wang T, Pei Z, Zhang W, Liu B, Langenbach R, Lee C, Wilson B, Reece JM et al (2005) MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. FASEB J 19(9):1134\u20131136","journal-title":"FASEB J"},{"key":"455_CR46","doi-asserted-by":"crossref","first-page":"401264","DOI":"10.1155\/2012\/401264","volume":"2012","author":"LJ Peterson","year":"2012","unstructured":"Peterson LJ, Flood PM (2012) Oxidative stress and microglial cells in Parkinson\u2019s disease. Mediat Inflamm 2012:401264","journal-title":"Mediat Inflamm"},{"issue":"28","key":"455_CR47","doi-asserted-by":"crossref","first-page":"25283","DOI":"10.1074\/jbc.M109145200","volume":"277","author":"ME Figueiredo-Pereira","year":"2002","unstructured":"Figueiredo-Pereira ME, Li Z, Jansen M, Rockwell P (2002) N-acetylcysteine and celecoxib lessen cadmium cytotoxicity which is associated with cyclooxygenase-2 up-regulation in mouse neuronal cells. J Biol Chem 277(28):25283\u201325289","journal-title":"J Biol Chem"},{"issue":"5","key":"455_CR48","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","volume":"100","author":"RL Hunter","year":"2007","unstructured":"Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG et al (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100(5):1375\u20131386","journal-title":"J Neurochem"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0455-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0455-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0455-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:36:50Z","timestamp":1658795810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0455-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["455"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0455-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}